; or (2) affect the preemption of any State insurance measure otherwise inconsistent with and preempted by Federal law. (q) Retention of authority of Federal financial regulatory agencies Nothing in this section or section 314 shall be construed to limit the authority of any Federal financial regulatory agency, including the authority to develop and coordinate policy, negotiate, and enter into agreements with foreign governments, authorities, regulators, and multinational regulatory committees and to preempt State measures to affect uniformity with international regulatory agreements. (r) Retention of authority of United States Trade Representative Nothing in this section or section 314 shall be construed to affect the authority of the Office of the United States Trade Representative pursuant to section 141 of the Trade Act of 1974 ( 19 U.S.C. 2171 ) or any other provision of law, including authority over the development and coordination of United States international trade policy and the administration of the United States trade agreements program. (s) Congressional testimony The Independent Insurance Advocate shall appear before the Committee on Financial Services of the House of Representatives and the Committee on Banking, Housing, and Urban Affairs at semi-annual hearings and shall provide testimony, which shall include submitting written testimony in advance of such appearances to such committees and to the Committee on Ways and Means of the House of Representatives and the Committee on Finance of the Senate, on the following matters: (1) Office activities The efforts, activities, objectives, and plans of the Office. (2) Section 313(l) actions Any actions taken by the Office pursuant to subsection (l) (regarding preemption pursuant to covered agreements). (3) Insurance industry The state of, and developments in, the insurance industry. (4) U.S. and global insurance and reinsurance markets The breadth and scope of the global insurance and reinsurance markets and the critical role such markets plays in